Connect with us

coronavirus

AstraZeneca says has submitted full data for European approval of COVID shot

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

AstraZeneca has submitted full data to pursue a conditional marketing authorisation application from the European Medicines Agency, a spokesman said on Wednesday after an EMA official said more data was needed, writes Alistair Smout.

“We can confirm that the we have submitted a full data package to support an application for conditional marketing authorization for the AstraZeneca COVID-19 vaccine to the European Medicines Agency,” the spokesman said.

“AstraZeneca has been submitting data on a rolling basis and will continue to work closely with the EMA to support the start of a formal CMA application process.”

Share this article:

Share this:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.

Trending